Sanofi Must Divulge Docs In FCA Fight Over Cancer Drug

Law360 (May 22, 2018, 4:57 PM EDT) -- A Pennsylvania federal judge has ordered Sanofi to hand over hundreds of documents, including any warnings that food and drug regulators may have issued, said to pertain to a suit alleging it marketed off-label uses of a cancer drug. 

In a pair of two-page orders, U.S. District Judge Lawrence F. Stengel ordered the drugmaker to divulge documents it had asserted attorney-client privilege over in a False Claims Act dispute. 

Judge Stengel based the decision on the testimony of employee-turned-whistleblower Yoash Gohil, who complained that the company was trying to shield documents that clearly fell outside assertions of privilege, such as emails...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS